Medical device firm ulrich medical USA has introduced a next-generation vertebral body replacement (VBR) device to the country’s spine implant market.
Referred to as Solidity, the device recently secured the US Food and Drug Administration (FDA) clearance for the surgical reconstruction of spinal defects.
The titanium implant consists of a main centrepiece with 625 end cap configurations in a single set. It can be used with a variety of implants based on a patients’ individual anatomy.
Solidity is designed to allow a maximum range of device access in order to support any surgical method. The device also enables revision and fine-tuning of a construct to fit patient anatomy.
ulrich medical chief commercial officer Erika Laskey said: “We are very pleased to release the Solidity VBR to the market in response to continued surgeon demand for additional corpectomy treatment options for their patients.
“The Solidity product incorporates more than forty years of our unparalleled experience in the research, development, manufacturing and commercialisation of expandable spine implant technologies worldwide.”
Founded in 1912 in Germany, ulrich medical offers spinal implant systems, imaging diagnostics, surgical instruments and hospital devices in more than 80 countries.
Solidity vertebral body replacement device expands the company’s spinal implants portfolio, which comprises expandable VBRs, interbody cages, rod-screw systems and plates.
The expandable VBRs by the company include Small and Omni VBR, ADDplus, obelisc and obelisc LE.
The interbody cages consist of an anterior cervical interbody device, PEEK cages and titanium cages, while the rod-screw systems are neon, uCentum and flamenco.
ulrich medical plates include cervical plate systems uNion and mambo, as well as golden gate lateral plate system.